🔗 Permalink

Inventor profile of:

Mark B. Abelson

City:

Andover, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-04-03

Top Assignees for applications by Mark B. Abelson

The entities that hold a legal rights for patent applications filed by inventor Abelson Mark B.:

ACIEX THERAPEUTICS, INC. 5 Westborough, MA United States
Ophthalmic Research Associates, Inc. 3 North Andover, MA United States
ACIEX THERAPEUTICS, INC. 2 Boston, MA United States
Vistakon Pharmaceuticals, LLC 2 Jacksonville, FL United States
Foresight Biotherapeutics, Inc. 1 New York, NY United States
Aciex, Inc. 1 Westborough, MA United States

Recent patent applications by Abelson Mark B.

Mark B. Abelson from Andover, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-03

US20250108059A1

Human necessities

TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE

#2 | 2024-02-22

US20240058355A1

Human necessities

TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE

#3 | 2023-06-15

US20230181594A1

Human necessities

TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE

#4 | 2022-12-29

US20220409047A1

Human necessities

APPARATUS FOR CAPTURING AN IMAGE OF THE EYE

#5 | 2021-02-04

US20210030762A1

Human necessities

TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE

#6 | 2017-03-09

US20170065605A1

Human necessities

Ophthalmic compositions containing alcaftadine

#7 | 2012-04-19

US20120093876A1

Human necessities

Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions

#8 | 2012-02-02

US20120027716A1

Human necessities

Povidone Iodine, A Novel Alternative Preservative For Ophthalmic Compositions

#9 | 2011-10-20

US20110257136A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#10 | 2010-12-09

US20100311688A1

Human necessities

OPHTHALMIC FORMULATIONS, METHODS OF MANUFACTURE, AND METHODS OF USING SAME

#11 | 2010-09-23

US20100240625A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#12 | 2010-09-23

US20100240624A1

Human necessities

Ophthalmic Formulations of Ketotifen and Methods of Use

#13 | 2010-05-27

US20100130580A1

Human necessities

Formulations and Methods for Treating Dry Eye

#14 | 2009-01-08

US20090010850A1

Human necessities

Formulations and methods for treating dry eye

#15 | 2008-12-18

US20080312194A1

Human necessities

Methods and compositions for normalizing meibomian gland secretions

#16 | 2008-02-28

US20080051385A1

Human necessities

Ocular allergy treatments with alcaftadine

#17 | 2008-02-14

US20080039398A1

Human necessities

Formulations and methods for treating dry eye

#18 | 2007-12-27

US20070299124A1

Human necessities

Formulations and methods for treating dry eye

#19 | 2007-12-27

US20070297981A1

Human necessities

Formulations and methods for treating dry eye

#20 | 2007-11-01

US20070254841A1

Human necessities

Formulations and methods for treating dry eye

#21 | 2006-11-30

US20060270592A1

Human necessities

Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions

#22 | 2005-10-27

US20050239745A1

Human necessities

Novel topical ophthalmic formulations

InventorID:

1816417 ⎘